Effectiveness of triclosan in the management of radiation-induced oral mucositis: A randomized clinical trial

Journal of Cancer Research and Therapeutics

Volumn 6, Issue 4, 2010, Pages 466-472

  Satheeshkumar, P S ^a   Chamba, Moideen Sha ^a   Balan, Anita ^a   Sreelatha, K T ^a   Bhatathiri, V N ^b   Bose, Tinky ^a  

^a GOVERNMENT DENTAL COLLEGE   (India)

^b REGIONAL CANCER CENTRE   (India)

Author keywords

Oral cancer; radiation mucositis; triclosan

Indexed keywords

BICARBONATE; MOUTHWASH; TRICLOSAN;

ADULT; AGED; ARTICLE; BODY WEIGHT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHEMA; FEMALE; FOLLOW UP; FOOD INTAKE; HUMAN; MALE; MOUTH CANCER; MUCOSA INFLAMMATION; PAIN; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SYMPTOM;

ANTI-INFECTIVE AGENTS, LOCAL; HUMANS; MOUTH NEOPLASMS; RADIOTHERAPY; STOMATITIS; TRICLOSAN;

EID: 79952393279     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.77109     Document Type: Article

References (33)

1. Shah J P, Gil Z. Current concepts in management of oral cancer surgery. Oral Oncol 2009;45:394-401.
2. Curado M P, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al., editors. Cancer Incidence in Five Continents. Vol. 9. Lyon, IARC: IARC Scientific Publications No. 160; 2007.
3. Yao M, Epstein JB, Modi BJ, Pytynia KB, Mundt AJ, Feldman LE. Current surgical treatment of squamous cell carcinoma of the head and neck. Oral Oncol 2007;43:213-23. (Pubitemid 46228018)
4. Sonis ST. Is mucositis an inevitable consequence of intensive therapy for hematologic cancers? Nat Clin Pract Oncol 2005;2:134-5. (Pubitemid 40823163)
5. Keefe DM. Mucositis guidelines: What have they achieved, and where to from here? Support Care Cancer 2006;14:489-91.
6. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Cancer 2008;113:2704-13.
7. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004;100:1995-2025. (Pubitemid 38528741)
8. Loprinzi CL, Dose AM. Studies on the prevention of 5-fluorouracilinduced oral mucositis. NCI Monogr 1990;9:93-4. (Pubitemid 20246035)
9. Sonis ST, Sonis AL, Lieberman A. Oral complications in patients receiving treatment for malignancies other than the head and neck. J Am Dent Assoc 1978;97:486-72.
10. Sonis ST, Costa J W, Evitts SM, Lindquist, LE, Nicholson M. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy. Oral Surg Oral Med Oral Pathol 1992;74:749-55. (Pubitemid 23005444)
11. Lichtman SM. Physiological aspects of aging: Implications for the treatment of cancer. Drugs Aging 1995;7:212-25.
12. Overholser CD, Peterson DE, Williams LT, Schimpff SC. Periodontal infections in patients with acute nonlymphocytic leukaemia: Prevalence of acute exacerbations. Arch Intern Med 1982;142:551-4. (Pubitemid 12190746)
13. Levine RS. Saliva 1. The nature of saliva. Dent Update 1989;4:102-6.
14. Dreizen S, Brown LR, Handler S, Johnston DA. Radiation induced xerostoma in cancer patients: Effects on salivary and serum electrolytes. Cancer 1976;38:273-8.
15. Panagakos FS, Volpe AR, Petrone ME, DeVizio W, Davies RM, Proskin HM. Advanced oral antibacterial/anti-inflammatory technology: A comprehensive review of the clinical benefits of a triclosan/copolymer/fluoride dentifrice. J Clin Dent 2005;16: S1-19. (Pubitemid 43309672)
16. Lang N P, Sander L, Barlow A, Brennan K, White DJ, Bacca L, et al. Experimental gingivitis studies: Effects of triclosan and triclosancontaining dentifrices on dental plaque and gingivitis in three-week randomized controlled clinical trials. J Clin Dent 2002;13:158-66.
17. Welk A, Splieth CH, Schmidt-Martens G, Schwahn CH, Kocher T, Kramer A, et al. The effect of a polyhexamethylene biguanide mouthrinse compared with a triclosan rinse and a chlorhexidine rinse on bacterial counts and 4-day plaque re-growth. J Clin Periodontol 2005;32:499-505. (Pubitemid 40627358)
18. Regos J, Hitz HR. Investigations on the mode of action of triclosan, a broad spectrum antimicrobial agent. Zentralbl Bakteriol Orig A 1974;226:390-401.
19. Escalada MG, Russell AD, Maillard J Y, Ochs D. Triclosan-bacteria interactions: Single or multiple target sites? Lett Appl Microbiol 2005;41:476-81. (Pubitemid 41735618)
20. Furie JE, Schenkel AG. Broad spectrum bacteriostat. Soap Cosmetics Chemical Specialities 1988;44:47-122.
21. Lindhe J, Rosling B, Socransky SS, Volpe TR. The effect of a triclosancontaining dentifrice on established plaque and gingivitis. J Clin Periodontol 1993;20:327-34. (Pubitemid 23274600)
22. Furuichi Y, Ramberg P, Krok L, Lindhe J. Short-term effects of triclosan on healing following subgingival scaling. J Clin Periodontol 1997;24:777-82. (Pubitemid 127731624)
23. Kjærheim V, Waaler SM. Experiments with Triclosan-Containing Mouthrinses: Dose Response-and an Attempt to Locate the Receptor Site (S) of Triclosan. Advances in Dental Researc. 1994;8:302-6.
24. Coleman EJ, Esposito A, Affitto J. Triclosan prevents SLS cytotoxicity to human gingival fibroblasts. J Dent Res 1992:72:1837,.
25. Gaffer A, Scherl D, Affitto J, Coleman IJ. The effect of triclosan on mediators of gingival inflammation. J Clin Periodontol 1995;22:480-4.
26. Skaare AB, Herlofson BB, Barkvoll P. Mouthrinses containing triclosan reduce the incidence of recurrent aphthous ulcers (RAU). J Clin Periodontol 1996;23:778-81. (Pubitemid 126732030)
27. Oguchi M, Ikeda H, Watanabe T, Shikama N, Ohata T, Okazaki Y, et al. Experience of 23 patients > 90 years of age treated with radiation therapy. Int J Radiat Oncol Biol Phys 1998;41:407-13. (Pubitemid 28243555)
28. Satheesh Kumar PS, Balan A, Sankar A, Bose T. Radiation induced oral mucositis. Indian J Palliat Care 2009;15:95-102.
29. Borowski B, Benhamou E, Pico JL, Laplanche A, Margainaud J P, Hayat M. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: A randomized controlled trial comparing two protocols of dental care. Eur J Cancer B Oral Oncol 1994;30:93-7. (Pubitemid 24136727)
30. Foote RL, Loprinzi CL, Frank AR. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation induced mucositis. J Clin Oncol 1994;12:2630-3. (Pubitemid 24379649)
31. Shieh SH, Wang ST, Tsai ST, Tseng CC. Mouth care for nasopharyngeal cancer patients undergoing radiotherapy. Oral Oncol 1997;33:36-40.
32. Sonis ST. Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 1998;34:39-43. (Pubitemid 28210529)
33. Kjaerheim V, Skaare A, Barkvoll P, Rölla G. Antiplaque, antibacterial, and anti-inflammatory properties of triclosan mouthrinses in combination with zinc citrate or polyvinylmethylether maleic acid (PVM-MA) copolymer. Eur J Oral Sci 1996;104:529-34. (Pubitemid 126782210)